Skip to main content

Info on low-tech vision aids

I"m posting this simply to share information with any readers who might benefit. Please note that in the past you had to be in New York to take advantage of these sessions - now they are being broadcast on the Web so you can attend from anywhere!

SAVE THE DATE



Monday, September 27, 2010



The Computer Center for Visually Impaired People (CCVIP) at


Baruch College Invites You to a


Technology Demonstration featuring




Make Life a Little Easier with Some Low Tech Solutions




Time: 2:00-4:00pm and 7:00-9:00pm




Where: Baruch College 55 Lexington Ave. Room 14-270






One entrance is on the south east side of 25th Street between 3rd and Lex Ave. in the middle of the block. It’s directly across the street from CCVIP's classroom building. The 2nd entrance is on the north east corner of 24th Street and Lexington Ave. This entrance has stairs. There is a ramp at the far end of the stairs on 24th street.


What: Join us as we launch the second year of the Technology Demo Center. Come with us, back to a simpler time, when not everything we touched required a degree in computer electronics. In this session, we will look at some of the lower tech solutions that visually impaired people can use to make life just a little bit easier. Our presentation will be led by a vision rehabilitation professional demonstrating some of the products and devices recommended for people dealing with vision loss.


Admission: Free


Reservations: Call 646-312-1420


If you are unable to join us in person, watch it on the web at the






Address below:


www.baruch.cuny.edu/ccvip-live-event


Also mark your calendars for Thursday, November 18, 2010. In this session we will look at the latest in note taking devices. How do these devices work? What do these devices do? How much do they cost? How will they impact the way I work or study?




Lisa F. Saunders


646-312-1420


lisa.saunders@baruch.cuny.edu







Labels:

Comments

Post a Comment

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for
1 comment
Read more

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.
Post a Comment
Read more

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria
Post a Comment
Read more